Vaxart Inc (NASDAQ: VXRT) kicked off on Friday, down -5.12% from the previous trading day, before settling in for the closing price of $0.72. Over the past 52 weeks, VXRT has traded in a range of $0.52-$1.54.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 1341.69% over the last five years. While this was happening, its average annual earnings per share was recorded 16.67%. With a float of $225.47 million, this company’s outstanding shares have now reached $227.44 million.
The firm has a total of 125 workers. Let’s measure their productivity. In terms of profitability, gross margin is 62.52%, operating margin of -611.49%, and the pretax margin is -614.19%.
Vaxart Inc (VXRT) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Vaxart Inc is 0.87%, while institutional ownership is 24.36%. The most recent insider transaction that took place on Jun 18 ’24, was worth 13,578. In this transaction Director of this company bought 20,000 shares at a rate of $0.68, taking the stock ownership to the 78,125 shares.
Vaxart Inc (VXRT) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported -0.11 earnings per share (EPS), higher than consensus estimate (set at -0.18) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 16.67% per share during the next fiscal year.
Vaxart Inc (NASDAQ: VXRT) Trading Performance Indicators
Take a look at Vaxart Inc’s (VXRT) current performance indicators. Last quarter, stock had a quick ratio of 4.54. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.46, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.41 in one year’s time.
Technical Analysis of Vaxart Inc (VXRT)
Analysing the last 5-days average volume posted by the [Vaxart Inc, VXRT], we can find that recorded value of 1.3 million was lower than the volume posted last year of 2.5 million. As of the previous 9 days, the stock’s Stochastic %D was 10.26%. Additionally, its Average True Range was 0.05.
During the past 100 days, Vaxart Inc’s (VXRT) raw stochastic average was set at 24.61%, which indicates a significant increase from 1.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 49.52% in the past 14 days, which was lower than the 74.07% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8237, while its 200-day Moving Average is $0.8821. Now, the first resistance to watch is $0.7163. This is followed by the second major resistance level at $0.7472. The third major resistance level sits at $0.7643. If the price goes on to break the first support level at $0.6683, it is likely to go to the next support level at $0.6512. Now, if the price goes above the second support level, the third support stands at $0.6203.
Vaxart Inc (NASDAQ: VXRT) Key Stats
The company with the Market Capitalisation of 147.93 million has total of 177,425K Shares Outstanding. Its annual sales at the moment are 7,380 K in contrast with the sum of -82,470 K annual income. Company’s last quarter sales were recorded 6,400 K and last quarter income was -16,470 K.
